Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Schizophrenia (Disease Or Phenotype)

Omim:MTHU015654

Nci:C3362

Msh:D012559

Mondo:MONDO:5090

Medcin:MEDCIN:35742

Mdr:MDR:10039626

Lnc:MTHU020814

Id:e65b8177-8978-5f45-acd6-46155a0bdf78

Icpc2icd10eng:MTHU061444

Icd10cm:F20.9

Doid:DOID:5419

Chv:CHV:11086

Results found

Linked to

	Label	Description
	D-Aspartic Acid correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Etiocholanolone correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	D-lactic acid correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	androsterone correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	kynurenic acid correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	glycerin correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Cortisol Measurement correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	N-gamma-Glutamylglutamine correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	linoleic acid correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	2S-Aminobutyric acid correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

D-Aspartic Acid correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Etiocholanolone correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

D-lactic acid correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

androsterone correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

kynurenic acid correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

glycerin correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Cortisol Measurement correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

N-gamma-Glutamylglutamine correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

linoleic acid correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

2S-Aminobutyric acid correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.